Two new Co(II) and Ni(II) complexes with 3-(2-pyridyl)pyrazole-based ligand: Synthesis, crystal structures, and bioactivities

Department of Chemistry, Nankai University, T’ien-ching-shih, Tianjin Shi, China
CHEMICAL & PHARMACEUTICAL BULLETIN (Impact Factor: 1.38). 08/2007; 55(7):996-1001. DOI: 10.1248/cpb.55.996
Source: PubMed

ABSTRACT Two new Co(II) and Ni(II) complexes exhibiting DNA cytotoxic activities with 3-(2-pyridyl)pyrazole-based ligand, [Co(L)(3)](ClO(4))(2) (1) and [Ni(L)(3)](ClO(4))(2) (2) (L=1-[3-(2-pyridyl)-pyrazol-1-ylmethyl]-naphthalene) were synthesized and structurally characterized. Both 1 and 2 crystallized in the monoclinic system, space group P2(1)/c, for 1, a=12.8324(8), b=12.1205(8), c=33.27(2) A, beta=93.92(3) degrees and Z=4; for 2, a=12.8764(3), b=12.1015(3), c=33.2415(9) A, beta=93.998(1) degrees and Z=4. Among them, the Co(II) and Ni(II) ions were all coordinated by six N donors from three distinct L ligands. In addition, the cytotoxic activities of 1, 2 and L in vitro were evaluated against three different cancer cell lines HL-60 (human leukemia), BGC-823 (stomach cancer) and MDA-MB-435 (mammary cancer), respectively. The results showed that 1 exhibited significantly high cytotoxic activities against HL-60 and moderate activities against BGC-823 and MDA-MB-435. In order to further investigate the relationships between structures and DNA-binding behaviors of these complexes, the interactions of 1, 2 and L with calf thymus DNA (CT-DNA) were then subjected to thermal denaturation, viscosity measurements and spectrophotometric methods. The results indicated that 1 and 2 intercalated with DNA via L ligand. The intrinsic binding constants of 1, 2 and L with DNA were 1.6x10(4), 5.6x10(3) and 2.76x10(3) M(-1), respectively.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: New hexa-coordinated binuclear Ru(II) thiosemicarbazone complexes of the type {[(B)(EPh3)(CO)ClRu]2L} (where, E = P or As; B = PPh3 or AsPh3 or pyridine; L = mononucleating NS donor of N-substituted thiosemicarbazones) have been synthesized and characterized by elemental analysis, FT-IR, UV–vis and 31P{1H} NMR cyclic voltammetric studies. The DNA-binding studies of Ru(II) complexes with calf thymus DNA (CT-DNA) were investigated by UV–vis, viscosity measurements, gel-electrophoresis and fluorescence spectroscopy. The new complexes have been used as catalysts in CC coupling reaction and in the oxidation of alcohols to their corresponding carbonyl compounds by using NMO as co-oxidant and molecular oxygen (O2) atmosphere at ambient temperature. Further, the new binucleating thiosemicarbazone ligands and their Ru(II) complexes were also screened for their antibacterial activity against Klebsiella pneumoniae, Shigella sp., Micrococcus luteus, Escherichia coli and Salmonella typhi. From this study, it was found out that the activity of the complexes almost reaches the effectiveness of the conventional bacteriocide.
    Journal of Advanced Research 07/2012; 3(3):233–243. DOI:10.1016/j.jare.2011.07.005
  • [Show abstract] [Hide abstract]
    ABSTRACT: A new asymmetric N,N′-bis(substituent)oxamide ligand, N-phenolato-N′-(3-dimethylaminopropyl)oxamide (H3pdmapo), and two of its binuclear Cu(II) complexes with different terminal ligands, namely [Cu2(pdmapo)(phen)(H2O)](ClO4) (1) and [Cu2(pdmapo)(bpy)(CH3OH)](ClO4) (2), where phen = 1,10-phenanthroline and bpy = 2,2′-bipyridine, have been synthesized and characterized. The crystal structures of both complexes have been determined by single-crystal X-ray diffraction. Both structures contain binuclear Cu(II) cationic complexes with pdmapo3− ligands. The asymmetric pdmapo3− ligands bridge two Cu(II) atoms in the cis conformation and the Cu···Cu separations through the oxamide bridge are 5.2046(18) and 5.207(2) Å for complexes 1 and 2, respectively. The coordination environments of the two Cu(II) atoms in each binuclear complex are different. The copper occupying the inner site of the pdmapo3− ligand is four-coordinated in a CuN3O distorted square-planar environment, while the other is five-coordinated in a square pyramid geometry. In complex 1, O–H···O and C–H···O hydrogen bonds link the complex into a one-dimensional chain. In complex 2, O–H···O hydrogen bonds link the molecules to form a dimer, together with two types of strong π–π interactions, giving a two-dimensional network structure. The cytotoxicities and DNA-binding properties of H3pdmapo and the two complexes were studied. The experimental evidence suggests that the ligand binds to DNA via a groove binding mode, while the binuclear complexes bind intercalatively to DNA.
    Transition Metal Chemistry 02/2012; 38(1). DOI:10.1007/s11243-012-9662-8 · 1.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: DNA is the major target for a wide range of therapeutic substances. Thus, there has been considerable interest in the binding studies of small molecules with DNA. Interaction between small molecules and DNA provides a structural guideline in rational drug designing and in the synthesis of new and improved drugs with enhanced selective activity and greater clinical efficacy. Plant derived polyphenolic compounds have a large number of biological and pharmacological properties. Coumarin is a polyphenolic compound which has been extensively studied for its diverse pharmacological properties. However, its mode of interaction with DNA has not been elucidated. In the present study, we have attempted to ascertain the mode of binding of coumarin with calf thymus DNA (Ct-DNA) through various biophysical techniques. Analysis of UV–visible absorbance spectra and fluorescence spectra indicates the formation of complex between coumarin and Ct-DNA. Several other experiments such as effect of ionic strength, iodide induced quenching, competitive binding assay with ethidium bromide, acridine orange and Hoechst 33258 reflected that coumarin possibly binds to the minor groove of the Ct-DNA. These observations were further supported by CD spectral analysis, viscosity measurements, DNA melting studies and in silico molecular docking.
    International Journal of Biological Macromolecules 11/2014; 73. DOI:10.1016/j.ijbiomac.2014.10.017 · 3.10 Impact Factor